• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非输血依赖型地中海贫血患者新疾病严重程度评分系统的开发

Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia.

作者信息

Cappellini M Domenica, Porter John B, Musallam Khaled M, Kattamis Antonis, Viprakasit Vip, Galanello Renzo, Taher Ali T

机构信息

Universita di Milano, Ca Granda Foundation IRCCS, Milan, Italy.

University College London, London, United Kingdom.

出版信息

Eur J Intern Med. 2016 Mar;28:91-6. doi: 10.1016/j.ejim.2015.10.003.

DOI:10.1016/j.ejim.2015.10.003
PMID:26545830
Abstract

BACKGROUND

Patients with non-transfusion-dependent thalassemia (NTDT) present with a spectrum of disease severities. Since there are multiple pathophysiologies in such patients, tailoring treatment remains essential. Therefore, one simple, reliable tool would be beneficial to assess disease severity and tailor therapy, particularly for internal medicine specialists who may treat a variety of NTDT patients with a multitude of complications. This would allow for standardization of assessments leading to timely interventions and prevention of complications.

METHODS

A working group of NTDT experts was formed to develop a new disease severity scoring system for adult and pediatric patients with NTDT, based on parameters considered to be most pertinent in defining disease severity.

RESULTS

20 parameters were selected for inclusion in the disease severity scoring system. An additional six parameters, largely related to growth and development, were selected specifically for pediatric patients (≤ 16 years of age). Consensus of expert opinion was used to establish the selected methods of assessment for each parameter, based on feasibility and availability of technology, cost containment, and avoidance of patient risk.

CONCLUSION

We propose that this new disease severity scoring system for adult and pediatric NTDT patients could be developed into a practical tool for widespread clinical use.

摘要

背景

非输血依赖型地中海贫血(NTDT)患者存在一系列疾病严重程度。由于此类患者存在多种病理生理机制,因此量身定制治疗方案至关重要。因此,一个简单、可靠的工具将有助于评估疾病严重程度并量身定制治疗方案,特别是对于可能治疗各种伴有多种并发症的NTDT患者的内科专家而言。这将实现评估的标准化,从而实现及时干预并预防并发症。

方法

成立了一个NTDT专家工作组,以基于被认为在定义疾病严重程度方面最相关的参数,为成年和儿科NTDT患者开发一种新的疾病严重程度评分系统。

结果

20个参数被选入疾病严重程度评分系统。另外六个主要与生长发育相关的参数专门为儿科患者(≤16岁)选定。基于技术的可行性和可用性、成本控制以及避免患者风险,利用专家意见的共识来确定每个参数的选定评估方法。

结论

我们建议,这种针对成年和儿科NTDT患者的新疾病严重程度评分系统可以发展成为一种广泛应用于临床的实用工具。

相似文献

1
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia.非输血依赖型地中海贫血患者新疾病严重程度评分系统的开发
Eur J Intern Med. 2016 Mar;28:91-6. doi: 10.1016/j.ejim.2015.10.003.
2
Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.重型地中海贫血患者长期使用去铁酮治疗期间的肝纤维化和铁水平
Hemoglobin. 2006;30(2):215-8. doi: 10.1080/03630260600642534.
3
Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.非输血依赖型地中海贫血中的肺动脉高压:与临床参数、肝脏铁浓度及非转铁蛋白结合铁的相关性
Hematology. 2015 Dec;20(10):610-7. doi: 10.1179/1607845415Y.0000000014. Epub 2015 May 12.
4
Tricuspid regurgitation in patients with beta-thalassemia major.重型β地中海贫血患者的三尖瓣反流
Ann Hematol. 2004 Dec;83(12):779-83. doi: 10.1007/s00277-004-0954-8. Epub 2004 Sep 23.
5
A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score.泰国东北部非输血依赖型地中海贫血患者肺动脉高压预测风险评分:E-SAAN评分
Hematology. 2015 Aug;20(7):416-21. doi: 10.1179/1607845414Y.0000000211. Epub 2014 Nov 11.
6
Thalassemia.地中海贫血
Hematology Am Soc Hematol Educ Program. 2004:14-34. doi: 10.1182/asheducation-2004.1.14.
7
Severity scoring system to guide transfusion management in pediatric non-deletional HbH.指导小儿非缺失型血红蛋白H病输血管理的严重程度评分系统。
Pediatr Int. 2023 Jan-Dec;65(1):e15568. doi: 10.1111/ped.15568.
8
Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.至少接受地拉罗司治疗 3 年的β-地中海贫血患者的肝脏病理改善。
Gastroenterology. 2011 Oct;141(4):1202-11, 1211.e1-3. doi: 10.1053/j.gastro.2011.06.065. Epub 2011 Jul 7.
9
The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum.β-地中海贫血综合征患者眼部改变的光谱提示一种类似于弹力假黄瘤的病理学改变。
Ophthalmology. 2014 Mar;121(3):709-18. doi: 10.1016/j.ophtha.2013.10.016. Epub 2013 Dec 4.
10
Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications.重型β地中海贫血年轻患者的血清YKL-40:与丙型肝炎病毒感染、瞬时弹性成像测定的肝脏硬度及心血管并发症的关系
Blood Cells Mol Dis. 2016 Jan;56(1):1-8. doi: 10.1016/j.bcmd.2015.09.006. Epub 2015 Sep 28.

引用本文的文献

1
Molecular analysis of alpha- and beta-thalassemia in Meizhou region and comparison of gene mutation spectrum with different regions of southern China.梅州地区α-和β-地中海贫血的分子分析及与中国南方不同地区基因突变谱的比较。
J Clin Lab Anal. 2021 Dec;35(12):e24105. doi: 10.1002/jcla.24105. Epub 2021 Nov 9.
2
Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.HBB 基因型对塞浦路斯依赖输血的地中海贫血患者队列生存的影响。
Haematologica. 2021 Sep 1;106(9):2458-2468. doi: 10.3324/haematol.2020.260224.